DESCRIPTION

Peri-Colace® (docusate sodium and standardized senna concentrate) is a combination stimulant laxative and stool softener

Peri-Colace® Tablets contains the following:

Active Ingredient: contains 50 mg of docusate sodium and 8.6 mg of sennosides

Inactive Ingredients: carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dicalcium phosphate, FD&C Blue No. 2, FD&C Red No. 40, hypromellose, magnesium stearate, microcrystalline cellulose, PEG 400, sodium benzoate, stearic acid, titanium dioxide

USES

Relieves occasional constipation (irregularity). Generally produces bowel movement in 6 to 12 hours.

WARNINGS

Do not use laxative products for longer than 1 week unless told to do so by a doctor; if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if you have stomach pain, nausea, vomiting, noticed a sudden change in bowel habits that lasts over 2 weeks. Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE


doses may be taken as a single daily dose or in divided doses preferably in the evening
adults and children 12 years and over	take 2-4 tablets daily
children 6 to under 12 years of age	take 1-2 tablets daily
children 2 to under 6 years of age	take up to 1 tablet daily
children under 2	ask a doctor

Other information

each tablet contains: calcium 20mg, sodium 4mg VERY LOW SODIUM

store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F).

Keep tightly closed.

HOW SUPPLIED

Tablets: Box of 10. Bottles of 30 and 60.

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.